33
/es/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
November 1, 2025
3512549
319423
2
Public Timelines
FAQ Obtener premium

1 ene 1996 año - Anastrozole

Descripción:

For postmenopausal women, the Food and Drug Administration (FDA) recommends anastrozole for the treatment of advanced breast cancer with an estrogen receptor positive. Anastrozole is the first aromatase inhibitor to be approved for cancer therapy (a drug that inhibits the development of estrogen in the body).

Añadido al timeline:

14 nov 2019
0
0
302

fecha:

1 ene 1996 año
Ahora mismo
~ 29 years ago